Cellectis S.A. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K, dated May 21, 2025, reports on corporate governance events for Cellectis S.A., a foreign private issuer headquartered in Paris, France. The filing announces the upcoming Combined General Meeting of Shareholders scheduled for June 26, 2025, and discloses a change in the composition of the Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder meeting logistics rather than financial performance.
Material Changes
- Board Resignation: Pierre Bastid has resigned from the Board of Directors. The resignation is effective as of the close of the Combined General Meeting of Shareholders.
- Reason for Departure: The Company states that Mr. Bastid's resignation is not the result of any disagreement with the Company regarding operations, policies, or practices.
Outlook, Risks, and Management Commentary
Management has scheduled the Combined General Meeting of Shareholders for June 26, 2025, at 2:30 p.m. Paris time at the Biopark auditorium in Paris. Additional details and the Notice of Meeting are available on the Company's investor website. No specific financial guidance, risk factors, or unusual items were disclosed in this filing.
Key Facts for Investor Verification
- Confirm the exact date and time of the Combined General Meeting (June 26, 2025).
- Verify the effective date of Pierre Bastid's resignation relative to the shareholder meeting.
- Review the attached Notice of Combined Shareholders' Meeting (Exhibit 99.1) for specific resolutions to be voted upon.
- Check the Company's website for any updates regarding the appointment of a replacement director.